Genetic variants of ApoE and ApoER2 differentially modulate endothelial function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 37, 2014, Pages 13493-13498

  Ulrich, Victoria ^a   Konaniah, Eddy S ^b   Herz, Joachim ^c   Gerard, Robert D ^a   Jung, Eunjeong ^a   Yuhanna, Ivan S ^a   Ahmed, Mohamed ^a   Hui, David Y ^b   Mineo, Chieko ^a   Shaul, Philip W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8; MUTANT PROTEIN;

3T3 CELL LINE; ANIMAL; BOVINE; CAROTID ARTERY; CELL ADHESION; CELL MOTION; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; HUMAN; METABOLISM; MONOCYTE; MOUSE; NEOINTIMA;

3T3 CELLS; ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CAROTID ARTERIES; CATTLE; CELL ADHESION; CELL MOVEMENT; ENDOTHELIAL CELLS; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MICE; MONOCYTES; MUTANT PROTEINS; NEOINTIMA; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84907289344     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1402106111     Document Type: Article

References (31)

1. Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141(2):137-147.
2. Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50(Suppl): S183-S188.
3. Shen GQ, et al. (2007) An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet 81(4):780-791.
4. Wang Q, et al. (2004) Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 74(2):262-271.
5. Martinelli N, et al. (2009) Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. BMC Med Genet 10:41.
6. Eichner JE, et al. (2002) Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol 155(6):487-495.
7. Greenow K, Pearce NJ, Ramji DP (2005) The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl) 83(5):329-342.
8. Scuteri A, et al. (2001) Is the apoE4 allele an independent predictor of coronary events? Am J Med 110(1):28-32.
9. Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52(1):131-145.
10. Holtzman DM, Herz J, Bu G (2012) Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2(3): a006312.
11. Ramesh S, et al. (2011) Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J Clin Invest 121(1):120-131.
12. Riddell DR, Sun XM, Stannard AK, Soutar AK, Owen JS (2001) Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane. J Lipid Res 42(6):998-1002.
13. Shaul PW (2002) Regulation of endothelial nitric oxide synthase: Location, location, location. Annu Rev Physiol 64:749-774.
14. Mineo C, Shaul PW (2012) Regulation of eNOS in caveolae. Adv Exp Med Biol 729: 51-62.
15. Yue L, et al. (2012) Apolipoprotein E enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase. Hypertension 60(4):1040-1046.
16. Sacre SM, Stannard AK, Owen JS (2003) Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells. FEBS Lett 540(1-3):181-187.
17. Korschineck I, et al. (2001) Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue. J Biol Chem 276(16):13192-13197.
18. May P, Bock HH, Nimpf J, Herz J (2003) Differential glycosylation regulates processing of lipoprotein receptors by gamma;-secretase. J Biol Chem 278(39):37386-37392.
19. Kim DH, et al. (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem 271(14):8373-8380.
20. Innerarity TL, Friedlander EJ, Rall SC, Jr, Weisgraber KH, Mahley RW (1983) The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J Biol Chem 258(20):12341-12347.
21. Eberlé D, et al. (2012) Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice. Arterioscler Thromb Vasc Biol 32(5):1116-1123.
22. Raffai RL, Dong LM, Farese RV, Jr, Weisgraber KH (2001) Introduction of human apolipoprotein E4 domain interaction into mouse apolipoprotein E. Proc Natl Acad Sci USA 98(20):11587-11591.
23. Kuhel DG, Zhu B, Witte DP, Hui DY (2002) Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler Thromb Vasc Biol 22(6):955-960.
24. Hui DY (2008) Intimal hyperplasia in murine models. Curr Drug Targets 9(3):251-260.
25. Ruiz J, et al. (2005) The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res 46(8):1721-1731.
26. Li X, Kypreos K, Zanni EE, Zannis V (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: Implications for the functions of apoE in the brain. Biochemistry 42(35):10406-10417.
27. Innerarity TL, Weisgraber KH, Arnold KS, Rall SC, Jr, Mahley RW (1984) Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. J Biol Chem 259(11):7261-7267.
28. Lieb W, et al. (2008) Lack of association of genetic variants in the LRP8 gene with familial and sporadic myocardial infarction. J Mol Med (Berl) 86(10):1163-1170.
29. Shen GQ, et al. (2013) Multi-allelic haplotype association identifies novel information different from single-SNP analysis: A new protective haplotype in the LRP8 gene is against familial and early-onset CAD and MI. Gene 521(1):78-81.
30. Miller MR, Megson IL (2007) Recent developments in nitric oxide donor drugs. Br J Pharmacol 151(3):305-321.
31. Carpenter AW, Schoenfisch MH (2012) Nitric oxide release: Part II. Therapeutic applications. Chem Soc Rev 41(10):3742-3752.